Related Experiment Video

Updated: Jul 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade

Noria Harir1, Cédric Boudot, Katrin Friedbichler

  • 1Inserm (EMI 351), Faculté de Médecine, Université de Picardie J. Verne, Amiens, France.

Blood
|June 27, 2008
PubMed

Insights

Constitutive activation of Stat5-PI3K-Akt signaling drives neoplastic mast cell (MC) development. Inhibiting Stat5 or Akt halts the growth of Kit D816V-mutated MC neoplasms, highlighting this pathway

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The D816V-mutated Kit is crucial for malignant transformation in mast cell (MC) neoplasms.
  • Understanding the signaling pathways involved is key to targeting these cancers.

Purpose of the Study:

  • To elucidate the role of the Stat5-PI3K-Akt cascade in neoplastic MC development.
  • To investigate the therapeutic potential of targeting this pathway in Kit D816V-mutated MCs.

Main Methods:

  • Retroviral transduction of active Stat5 (cS5(F)) in murine bone marrow progenitors.
  • Analysis of signaling pathways in primary neoplastic MCs from mastocytosis patients.
  • Gene silencing (knock-down) of Stat5 and Akt.

Main Results:

  • Constitutive Stat5 activation triggers PI3K and Akt, transforming progenitors into MCs.
  • Neoplastic Kit D816V(+) MCs exhibit activated Stat5, PI3K, and Akt.
  • Stat5 and Akt activation are essential for neoplastic MC growth and survival.

Conclusions:

  • The Stat5-PI3K-Akt signaling cascade is essential for Kit D816V-mediated neoplastic MC growth and survival.
  • Targeting Stat5 or Akt may represent a therapeutic strategy for mastocytosis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...